Physician profile
Christopher P Ryan
NPI 1467508135
$608.79
in general payments reported to CMS, 2019-2025
10 companies · $155 in 2025
The $155 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $112 · 2022: $28.44 · 2023: $100 · 2024: $213 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $468.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $136.50 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $129.87 | 2022-2025 | |
| Thd America, INC. | $95.98 | 2021 | |
| Shield Therapeutics INC | $56.57 | 2023-2025 | Accrufer |
| Astellas Pharma US INC | $47.80 | 2024 | Veozah |
| Abbott Laboratories | $43.89 | 2024 | Freestyle Libre 3 |
| Dynavax Technologies Corporation | $36.56 | 2023-2024 | Heplisav-B |
| E.R. Squibb & Sons, L.L.C. | $24.86 | 2024 | Eliquis |
| Viiv Healthcare Company | $20.75 | 2024 | Apretude |
| Bayer Healthcare Pharmaceuticals INC. | $16.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.